Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.90
+0.29 (3.81%)
At close: May 4, 2026, 4:00 PM EDT
7.89
-0.01 (-0.13%)
After-hours: May 4, 2026, 7:59 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $487.84 million as of May 4, 2026. Its market cap has increased by 650.12% in one year.
Market Cap
487.84M
Enterprise Value
374.79M
1-Year Change
650.12%
Ranking
Category
Stock Price
$7.90
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has increased from $354.80M to $487.84M, an increase of 37.50%. That is a compound annual growth rate of 12.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 469.93M | 144.08% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 496.75M |
| XOMA Royalty | 491.52M |
| Eupraxia Pharmaceuticals | 487.15M |
| Fulcrum Therapeutics | 483.42M |
| 4D Molecular Therapeutics | 480.91M |
| REGENXBIO | 477.98M |
| Prelude Therapeutics | 476.62M |
| ADC Therapeutics | 475.05M |